Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 11/20 | 0.79 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | THRA | P10827 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27698271 | 0.98 | FFAR1 (0.76) | FFAR1KEAP1ALDH1A1L3MBTL1TDP1 | |
| SCHEMBL1510710 | 0.94 | FFAR1 (0.71) | FFAR1KEAP1ALDH1A1L3MBTL1TDP1 | |
| SCHEMBL19914066 | 0.89 | FFAR1 (0.65) | FFAR1KEAP1ALDH1A1L3MBTL1TDP1 | |
| SCHEMBL9495863 | 0.89 | FFAR1 (0.65) | FFAR1KEAP1ALDH1A1L3MBTL1TDP1 | |
| SCHEMBL12087474 | 0.89 | FFAR1 (1.00) | FFAR1FFAR4 | |
| SCHEMBL69746 | 0.88 | FFAR1 (0.81) | FFAR1KEAP1L3MBTL1CA1CA2 | |
| SCHEMBL764952 | 0.87 | SMN1; SMN2 (0.67) | FFAR1ALDH1A1L3MBTL1TDP1KMT2A | |
| SCHEMBL7020238 | 0.86 | FFAR1 (0.66) | FFAR1KEAP1ALDH1A1L3MBTL1TDP1 | |
| Hydrochloric Acid SCHEMBL25264643 | 0.85 | FFAR1 (0.77) | FFAR1KEAP1L3MBTL1CA1CA2 | |
| SCHEMBL1066202 | 0.85 | MAPT (0.66) | FFAR1ALDH1A1L3MBTL1TDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 847 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-12304894-B2 | Derivatives of adamantyl oxadiazoles and pharmaceutically acceptable solvates, hydrates and salts thereof, pharmaceutical composition comprising same, synthesis method, suitable for use as effective and selective inhibitors of the reductase activity of the enzyme 11-beta dehydrogenase type 1 (11β-HSD1) | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (CL) | 2025-05-20 | — | — | US | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-117143097-A | Beta-carbopol compound, preparation method thereof and application of beta-carbopol compound in resisting Alzheimer disease | 中国人民解放军北部战区总医院 | 2023-12-01 | — | — | CN | claimed |
| US-20230047296-A1 | Nrf2 REGULATORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2023-02-16 | — | — | US | claimed |
| US-20220194909-A1 | DERIVATIVES OF ADAMANTYL OXADIAZOLES AND PHARMACEUTICALLY ACCEPTABLE SOLVATES, HYDRATES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING SAME, SYNTHESIS METHOD, SUITABLE FOR USE AS EFFECTIVE AND SELECTIVE INHIBITORS OF THE REDUCTASE ACTIVITY OF THE ENZYME 11-BETA DEHYDROGENASE TYPE 1 (11B-HSD1) | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (CL) | 2022-06-23 | — | — | US | claimed |
| CN-110167933-B | As αVAzole amides and amines as integrin inhibitors | 百时美施贵宝公司 | 2022-06-21 | — | — | CN | claimed |
| CN-112898137-A | Preparation method and application of acetophenone derivative | 安徽泽升科技有限公司 | 2021-06-04 | — | — | CN | claimed |
| WO-2020210922-A1 | DERIVATIVES OF ADAMANTYL OXADIAZOLES AND PHARMACEUTICALLY ACCEPTABLE SOLVATES, HYDRATES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING SAME, SYNTHESIS METHOD, SUITABLE FOR USE AS EFFECTIVE AND SELECTIVE INHIBITORS OF THE REDUCTASE ACTIVITY OF THE ENZYME 11-BETA DEHYDROGENASE TYPE 1 (11Β-HSD1) | PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE (CL) | 2020-10-22 | — | — | WO | claimed |
| EP-3688124-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | ExxonMobil Chemical Patents Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-6893687-B2 | Wetting with aqueous dispersion containing ultraviolet radiation crosslinkable resin, photoinitiator, corrosion inhibitor and wax; drying and curing without cracking or flaking | CHEMETALL GMBH (DE) | 2005-05-17 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-20040265964-A1 | Inducers of recombinant protein expression | IMMUNEX CORPORATION | 2004-12-30 | — | — | US | claimed |
| WO-2004096833-A2 | INDUCERS OF RECOMBINANT PROTEIN EXPRESSION | IMMUNEX CORPORATION (US) | 2004-11-11 | — | — | WO | claimed |
| US-20040022951-A1 | Method for coating metallic surfaces and use of substrates coated in such a way or coatings produced in such a way | CHEMETALL GMBH (DE) | 2004-02-05 | — | — | US | claimed |
| US-20030185990-A1 | Method for pretreating and coating metal surfaces prior to forming, with a paint-like coating and use of substrates so coated | CHEMETALL GMBH (DE) | 2003-10-02 | — | — | US | claimed |
| US-5006433-A | Printing plate precursors for electrophotographic plate-making purposes | FUJI PHOTO FILM CO., LTD. (JP) | 1991-04-09 | — | — | US | claimed |
| EP-0012942-B1 | ELECTROLYTIC PROCESS FOR PRODUCING BENZALDEHYDES | BASF Aktiengesellschaft (DE) | 1982-01-27 | — | — | EP | claimed |
| EP-0012942-A2 | Electrolytic process for producing benzaldehydes | BASF Aktiengesellschaft (DE) | 1980-07-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220194909-A1 | DERIVATIVES OF ADAMANTYL OXADIAZOLES AND PHARMACEUTICALLY ACCEPTABLE SOLVATES, HYDRATES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING SAME, SYNTHESIS METHOD, SUITABLE FOR USE AS EFFECTIVE AND SELECTIVE INHIBITORS OF THE REDUCTASE ACTIVITY OF THE ENZYME 11-BETA DEHYDROGENASE TYPE 1 (11B-HSD1) | HSD11B1, HSD11B2, CYP11B1 | FFAR1 695/4885KEAP1 1504/4885ALDH1A1 190/4885 |
| US-20040265964-A1 | Inducers of recombinant protein expression | AADAC, CRYAA, PMAIP1 | FFAR1 2596/4885KEAP1 4086/4885ALDH1A1 2178/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | FFAR1 3461/4885KEAP1 2845/4885ALDH1A1 1723/4885 |
| US-20230047296-A1 | Nrf2 REGULATORS | NFE2L2, KEAP1, NQO1 | FFAR1 823/4885KEAP1 2/4885ALDH1A1 621/4885 |
| US-12304894-B2 | Derivatives of adamantyl oxadiazoles and pharmaceutically acceptable solvates, hydrates and salts thereof, pharmaceutical composition comprising same, synthesis method, suitable for use as effective and selective inhibitors of the reductase activity of the enzyme 11-beta dehydrogenase type 1 (11β-HSD1) | HSD11B1, HSD11B2, HSD17B1 | FFAR1 623/4885KEAP1 1272/4885ALDH1A1 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.